These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24011579)

  • 1. Novel therapeutic strategy with hypoxia-inducible factors via reversible epigenetic regulation mechanisms in progressive tubulointerstitial fibrosis.
    Mimura I; Tanaka T; Nangaku M
    Semin Nephrol; 2013 Jul; 33(4):375-82. PubMed ID: 24011579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epigenetics in kidney diseases].
    Mimura I; Nangaku M
    Rinsho Byori; 2014 Feb; 62(2):180-9. PubMed ID: 24800494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure.
    Nangaku M
    J Am Soc Nephrol; 2006 Jan; 17(1):17-25. PubMed ID: 16291837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A primer on the epigenetics of kidney fibrosis.
    Tampe D; Zeisberg M
    Minerva Med; 2012 Aug; 103(4):267-78. PubMed ID: 22805619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel lnc RNA regulated by HIF-1 inhibits apoptotic cell death in the renal tubular epithelial cells under hypoxia.
    Mimura I; Hirakawa Y; Kanki Y; Kushida N; Nakaki R; Suzuki Y; Tanaka T; Aburatani H; Nangaku M
    Physiol Rep; 2017 Apr; 5(8):. PubMed ID: 28420760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of hypoxia in progressive chronic kidney disease and implications for therapy.
    Shoji K; Tanaka T; Nangaku M
    Curr Opin Nephrol Hypertens; 2014 Mar; 23(2):161-8. PubMed ID: 24378776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The balance of beneficial and deleterious effects of hypoxia-inducible factor activation by prolyl hydroxylase inhibitor in rat remnant kidney depends on the timing of administration.
    Yu X; Fang Y; Liu H; Zhu J; Zou J; Xu X; Jiang S; Ding X
    Nephrol Dial Transplant; 2012 Aug; 27(8):3110-9. PubMed ID: 22399494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiological response to hypoxia - from the molecular mechanisms of malady to drug discovery: epigenetic regulation of the hypoxic response via hypoxia-inducible factor and histone modifying enzymes.
    Mimura I; Tanaka T; Wada Y; Kodama T; Nangaku M
    J Pharmacol Sci; 2011; 115(4):453-8. PubMed ID: 21422728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor activation in diabetic kidney disease.
    Persson P; Palm F
    Curr Opin Nephrol Hypertens; 2017 Sep; 26(5):345-350. PubMed ID: 28538016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indoxyl sulfate signals for rapid mRNA stabilization of Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (CITED2) and suppresses the expression of hypoxia-inducible genes in experimental CKD and uremia.
    Tanaka T; Yamaguchi J; Higashijima Y; Nangaku M
    FASEB J; 2013 Oct; 27(10):4059-75. PubMed ID: 23792300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the renin-angiotensin system and chronic hypoxia of the kidney.
    Nangaku M; Fujita T
    Hypertens Res; 2008 Feb; 31(2):175-84. PubMed ID: 18360035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic regulation of hypoxia inducible factor in diseases and therapeutics.
    Nguyen MP; Lee S; Lee YM
    Arch Pharm Res; 2013 Mar; 36(3):252-63. PubMed ID: 23440580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of hypoxia and HIF-mediated hypoxia adaptive response in the progression of chronic kidney disease].
    Khamaisi M; Heyman SN
    Harefuah; 2009 Oct; 148(10):721-6, 732. PubMed ID: 20073404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure.
    Nangaku M
    Nephron Exp Nephrol; 2004; 98(1):e8-12. PubMed ID: 15361693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure.
    Nangaku M
    Intern Med; 2004 Jan; 43(1):9-17. PubMed ID: 14964574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines in epithelial-mesenchymal transition: a new insight into obstructive nephropathy.
    Bani-Hani AH; Campbell MT; Meldrum DR; Meldrum KK
    J Urol; 2008 Aug; 180(2):461-8. PubMed ID: 18550128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.
    Rapisarda A; Uranchimeg B; Scudiero DA; Selby M; Sausville EA; Shoemaker RH; Melillo G
    Cancer Res; 2002 Aug; 62(15):4316-24. PubMed ID: 12154035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia and Renal Tubulointerstitial Fibrosis.
    Li ZL; Liu BC
    Adv Exp Med Biol; 2019; 1165():467-485. PubMed ID: 31399980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors.
    Arjamaa O; Nikinmaa M
    Exp Eye Res; 2006 Sep; 83(3):473-83. PubMed ID: 16750526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of genetics and epigenetics to progression of kidney fibrosis.
    Tampe B; Zeisberg M
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv72-9. PubMed ID: 23975750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.